RP463: A stabilized technetium-99m complex of a hydrazino nicotinamide derivatized chemotactic peptide for infection imaging

Bioconjugate Chemistry

Volumn 10, Issue 5, 1999, Pages 884-891

  Edwards, D Scott ^a   Liu, Shuang ^a   Ziegler, Marisa C ^a   Harris, Anthony R ^a   Crocker, Andrew C ^a   Heminway, Stuart J ^a   Barrett, John A ^a   Bridger, Gary J ^b   Abrams, Michael J ^b   Higgins III, John D ^c  

^a DUPONT COMPANY   (United States)

^b GENZYME CORPORATION   (United States)

^c McNeil Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CHLORINE COMPOUNDS; COMPLEXATION; LIGANDS; MASS SPECTROMETRY; TECHNETIUM COMPOUNDS;

CO-LIGANDS; DIRECT REDUCTION; ELECTROSPRAY MASS SPECTROMETRY; LIGAND COMPLEXES; PERTECHNETATE; POLYMORPHONUCLEAR LEUKOCYTES; POST INJECTION; RADIOLABELLING; SYNTHESISED; TECHNETIUM-99M;

PEPTIDES;

EID: 0033200233     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990049y     Document Type: Article

References (35)

1. Fischman, A. J., Babich, J. W., and Rubin, R. H. (1994) Infection imaging with technetium-99m-labeled chemotactic peptide analogues. Semin. Nucl. Med. 24, 154-168.
2. 99mTc-labeled chemotactic peptides for studies of inflammation in vivo. Bioconjugate Chem. 9, 208-217.
3. Babich, J. W., Solomon, H., Pike, M. C., Kroon, D., Graham, W., Abrams, M. J., Tompkins, R. G., Rubin, R. H., and Fischman, A. J. (1993) Technetium-99m-labeled hydrazino nicotinamide derivatized chemotactic peptide analogues for imaging focal sites of bacterial infection. J. Nucl. Med. 34, 1964-1974.
4. 99mTc-labeled hydrazino nicotinic acid derivatized chemotactic peptides. Nucl. Med. Biol. 22, 25-30.
5. Fischman, A. J., Babich, J. W., and Strauss, H. W. (1993) A ticket to ride: peptide radiopharmaceuticals. J. Nucl. Med. 34, 2253-2263.
6. Fischman, A. J., Rauh, D., Solomon, H., Babich, J. W., Tompkins, R. G., Kroon, D., Strauss, H. W., and Rubin, H. R. (1993) In vivo bioactivity and biodistribution of chemotactic peptide analogues in nonhuman primates. J Nucl. Med. 34, 2130-2134.
7. 111In IgG. Nucl. Med. Biol. 22, 643-648.
8. Babich, J. W., Graham, W., Barrow, S. A., Dragotakes, S. C., Tompkins, R. H., Rubin, R. H., and Fischman, A. J. (1993) Technetium-labeled chemotactic peptides: comparison with Indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. J. Nucl. Med. 34, 2176-2181.
9. Moyer, B. R., Vallabhajosula, S., Lister-James, J., Bush, L. R., Cyr, J. E., Snow, D. A., Bastidas, D., Lipszyc, H., and Dean, R. T. (1996) Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection. J. Nucl. Med. 37, 673-679.
10. Goodbody, A. E., Ballinger, J., Tran, L. L., Sumner-Smith, M., Lau, F., Meghji, K., and Pollak, A. (1994) A new Tc-99m labeled peptide inflammation imaging agent. Eur. J. Nucl. Med. 21, 790 (abstr. 262).
11. Cavelier, V., Goodbody, A. E., Tran, L. L., Bossuyt, A., and Thornback, J. (1996) Human dosimetry of Tc99m-RP128, a potential inflammation imaging agent. Eur. J. Nucl. Med. 23, 1131 (abstr. OMo398).
12. Peers, S. H., Tran, L. L., Eriksson, S. J., Ballinger, J., and Goodbody, A. E. (1995) Imaging a model of colitis with RP128, a Tc-99m-chelated tuftsin antagonist. J. Nucl. Med. 36, 114P (abstr. 465).
13. Fischman, A. J., Pike, M. C., Kroon, D., Fuccello, A. J., Rexinger, D., tenKate, C., Wilkinson, R., Rubin, R. H., and Strauss, H. W. (1991) Imaging focal sites of bacterial infection in rats with indium-III-labeled chemotactic peptide analogues. J. Nucl. Med. 32, 483-491.
14. van der Laken, C. J., Boerman, O. C., Oyen, W. J. G., van den Ven, M. T. J., Edwards, D. S., Barrett, J. A., van der Meer, J. W. M., and Corstens, F. H. M. (1997) Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation. J. Nucl. Med. 38, 1310-1315.
15. Babich, J. W., Tompkins, R. H., Graham, W., Barrow, S. A., and Fischman, A. J. (1997) Localization of radiolabeled chemotactic peptide at focal site of Esckrichia coli infection in rabbits: evidence for a receptor-specific mechanism. J. Nucl. Med. 38, 1316-1322.
16. Edwards, D. S., Barrett, J. A., Liu, S., Ziegler, M. C., Mazaika, T., Vining, M., Bridger, G., Higgins, J., III, and Abrams, M. J. (1996) A stabilized Tc-99m complex of a chemotactic peptide-HYNIC conjugate for imaging infection. Eur. J. Nucl. Med. 23, 1142 (abstr. Omo440).
17. Abrams, M. J., Juweid, M., tenKate, C. I., Schwartz, D. A., Hauser, M. M., Gaul, F. E., Fuccello, A. J., Rubin, R. H., Strauss, H. W., and Fischman, A. J. (1990) Technetiun-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31, 2022-2028.
18. 99mTc-protein conjugates. Bioconjugate Chem. 2, 334-336.
19. McAfee, J. G. (1990) What is the best method for imaging focal infections? J. Nucl. Med. 31, 413-416 (Editorial).
20. Claessens, R. A. M. J., Koenders, E. B., Oyen, W. J. G., and Corstens, F. H. M. (1996) Retention of technetium-99m in infectious foci in rats after release from technetium-99m labeled human nonspecific polyclonal immunoglobulin G: a dual-label study with hydrazino-nicotinamido and iminothiolano immunoglobulin. Eur. J. Nucl. Med. 23, 1536-1539.
21. 99mTc-human immunoglobulin (HIG)-first results of a new agent for the localization of infection and inflammation. Eur. J. Nucl. Med. 16, 649-655.
22. Barrow, S. A., Graham, W., Jyawook, S., Dragotakes, S. C., Solomon, H. F, Babich, J. W., Rubin, R. H., and Fischman, A. J. (1993) Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled white blood cells at sites of acute bacterial infection in rabbits. J. Nucl. Med. 34, 1975-1979.
23. Callahan, R. J., Barrow, S. A., Abrams, M. J., Rubin, R. H., and Fischman, A. J. (1996) Biodistribution and dosimetry of technetium-99m-hydrazinonicotinamide IgG: comparison with indium-111-DTPA-IgG. J. Nucl. Med. 37, 843-846.
24. 99mTc-labeled human polyclonal IgG. Nucl. Med. Biol. 21, 111-116.
25. 99mTc-hexamethylpropyleneamineoxime for labeling leukocytes and imaging inflammation. Lancet 2, 946-949.
26. Vorne, M., Soini, I., Lantto, T., and Paakkinen, S. (1989) Technetium-99m-HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate. J. Nucl. Med. 30, 1332-1336.
27. Charron, M., Orenstein, S. R., and Bhargava, S. (1994) Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes. J. Nucl. Med. 35, 451-455.
28. Peters, A. M. (1996) The choice of an appropriate agent for imaging inflammation. Nucl. Med. Commun. 17, 455-458.
29. Lange, J. M. A., Boucher, C. A. B., Hollak, C. E. M., Wiltink, E. H. H., Reiss, P., van Royen, E. A., Roos, M., Danner, S. D., and Goudsmit, J. (1990) Failure of zidovudine prophylaxis after accidental exposure to HIV-1. N. Eng. J. Med. 322, 1375-1377.
30. Rojas-Burke, J. (1990) Health officials reacting to infection mishaps. J. Nucl. Med. 33, 13-27.
31. 99mTc using aminocarboxylates as coligands. Bioconjugate Chem. 7, 63-71.
32. 99mTc. Bioconjugate Chem. 8, 146-154.
33. 99mTc. Bioconjugate Chem. 8, 155-160.
34. Solomon, H. F., Derlan, C. K., Beblavy, M., Jester, D., Santulll, R., Pike, M., Kroon, D., Hoey, K., and Fischman, A. J. (1994) Focal infection imaging using an In-111 labeled antagonist chemotactic peptide. J. Nucl. Med. 35, 45P (abstr. 172).
35. 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands. Bioconjugate Chem. 9, 583-595.